These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 8560406

  • 1. The factor V Leiden mutation which predisposes to thrombosis is not common in patients with antiphospholipid syndrome.
    Dizon-Townson D, Hutchison C, Silver R, Branch DW, Ward K.
    Thromb Haemost; 1995 Oct; 74(4):1029-31. PubMed ID: 8560406
    [Abstract] [Full Text] [Related]

  • 2. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
    Chopra N, Koren S, Greer WL, Fortin PR, Rauch J, Fortin I, Senécal JL, Docherty P, Hanly JG.
    J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
    [Abstract] [Full Text] [Related]

  • 3. Factor V Leiden is not common in children with portal vein thrombosis.
    Seixas CA, Hessel G, Ribeiro CC, Arruda VR, Annichino-Bizzacchi JM.
    Thromb Haemost; 1997 Feb; 77(2):258-61. PubMed ID: 9157577
    [Abstract] [Full Text] [Related]

  • 4. "Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds.
    Simioni P, Scudeller A, Radossi P, Gavasso S, Girolami B, Tormene D, Girolami A.
    Thromb Haemost; 1996 Mar; 75(3):422-6. PubMed ID: 8701401
    [Abstract] [Full Text] [Related]

  • 5. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB, Sturk A.
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [Abstract] [Full Text] [Related]

  • 6. [Leiden, G20210A mutations in prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome].
    Reshetniak TM, Patrushev LI, Stukacheva EA, Miroshnikov AI, Tikhonova TL, Nasonov EL, Alekberova ZS.
    Ter Arkh; 2000 Jul; 72(5):34-8. PubMed ID: 11109617
    [Abstract] [Full Text] [Related]

  • 7. Risk of thrombosis in patients with antiphospholipid antibodies and factor V Leiden mutation.
    Pablos JL, Caliz RA, Carreira PE, Atsumi T, Serrano L, Amengual O, Santiago B, Khamashta MA, Hughes GR, Gomez-Reino JJ.
    J Rheumatol; 1999 Mar; 26(3):588-90. PubMed ID: 10090167
    [Abstract] [Full Text] [Related]

  • 8. Coexistence of hereditary homocystinuria and factor V Leiden--effect on thrombosis.
    Mandel H, Brenner B, Berant M, Rosenberg N, Lanir N, Jakobs C, Fowler B, Seligsohn U.
    N Engl J Med; 1996 Mar 21; 334(12):763-8. PubMed ID: 8592550
    [Abstract] [Full Text] [Related]

  • 9. [Mutations of genes associated with thromboses in ischemic stroke in patients with primary antiphospholipid syndrome].
    Kalashnikova LA, Dobrynina LA, Patrusheva NL, Kovalenko TF, Patrushev LI, Aleksandrova EN, Berkovskiĭ AL, Sergeeva EV, Nasonov EL.
    Ter Arkh; 2005 Mar 21; 77(10):49-53. PubMed ID: 16320685
    [Abstract] [Full Text] [Related]

  • 10. Simple and rapid detection of factor V Leiden by allele-specific PCR amplification.
    Blasczyk R, Ritter M, Thiede C, Wehling J, Hintz G, Neubauer A, Riess H.
    Thromb Haemost; 1996 May 21; 75(5):757-9. PubMed ID: 8725719
    [Abstract] [Full Text] [Related]

  • 11. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
    Rintelen C, Pabinger I, Knöbl P, Lechner K, Mannhalter C.
    Thromb Haemost; 1996 Feb 21; 75(2):229-32. PubMed ID: 8815565
    [Abstract] [Full Text] [Related]

  • 12. Factor V Leiden mutation in patients with Behçet's disease.
    Oner AF, Gürgey A, Gürler A, Mesci L.
    J Rheumatol; 1998 Mar 21; 25(3):496-8. PubMed ID: 9517770
    [Abstract] [Full Text] [Related]

  • 13. Factor V Leiden in patients with acute coronary syndromes.
    Durante Mangoni E, Davies GJ, Tuddenham EG, Ruggiero G.
    Ann Ital Med Int; 1999 Mar 21; 14(1):15-9. PubMed ID: 10528420
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Rapid multiplex analysis for the factor V Leiden and prothrombin G20210A mutations associated with hereditary thrombophilia.
    Linfert DR, Rezuke WN, Tsongalis GJ.
    Conn Med; 1998 Sep 21; 62(9):519-25. PubMed ID: 9785636
    [Abstract] [Full Text] [Related]

  • 17. Arterial thrombosis and the role of thrombophilia.
    Boekholdt SM, Kramer MH.
    Semin Thromb Hemost; 2007 Sep 21; 33(6):588-96. PubMed ID: 17768691
    [Abstract] [Full Text] [Related]

  • 18. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J, Vayá A, Estellés A, Mira Y, Seguí R, Villa P, Ferrando F, Falcó C, Corella D, España F.
    Haematologica; 2000 Dec 21; 85(12):1271-6. PubMed ID: 11114134
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.
    Fábregues F, Tàssies D, Reverter JC, Carmona F, Ordinas A, Balasch J.
    Fertil Steril; 2004 Apr 21; 81(4):989-95. PubMed ID: 15066453
    [Abstract] [Full Text] [Related]

  • 20. Increased venous versus arterial thrombosis in the Factor V Leiden mouse.
    Cooley BC, Chen CY, Schmeling G.
    Thromb Res; 2007 Apr 21; 119(6):747-51. PubMed ID: 16793123
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.